Skip to main content
Equibles

BAKER BROS. ADVISORS LP

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 1263508 NEW YORK, NY
Back to IDYA Full portfolio

Position in IDYA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$186,723,818
+$55,225,939 QoQ
Shares Held
5,010,030
+26.9% QoQ
Ownership
5.19%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#5
of 286 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IDYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BAKER BROS. ADVISORS LP holds $18,875,530,286 across 78 Biotechnology names. IDYA ranks #15 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 30,762,330 $3,487,217,728
2 ONC
BeOne Medicines Ltd.
 8,801,567 $2,508,182,547
3 RVMD
Revolution Medicines, Inc.
 11,443,357 $2,143,111,898
4 MDGL
Madrigal Pharmaceuticals, Inc.
 2,143,131 $1,150,754,190
5 ACAD
Acadia Pharmaceuticals Inc
 42,912,904 $1,085,696,471
6 KYMR
Kymera Therapeutics, Inc.
 8,657,242 $992,725,940
7 INSM
INSMED Inc
 8,796,111 $937,841,354
8 CELC
Celcuity Inc.
 7,915,792 $828,150,159

All Filings in IDYA

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $186,723,818 5,010,030
2026-03-31 $131,497,879 3,946,515
2025-12-31 $125,102,814 3,618,826
2025-09-30 $89,124,831 3,275,444
2025-06-30 $44,535,662 2,118,728
2025-03-31 $17,397,574 1,062,123
2024-12-31 $27,296,561 1,062,123
2024-09-30 $33,648,056 1,062,123
2024-06-30 $37,291,138 1,062,123
2024-03-31 $46,605,957 1,062,123
2023-12-31 $37,790,336 1,062,123
2023-09-30 $28,656,078 1,062,123
2023-06-30 $24,959,890 1,062,123
2023-03-31 $11,433,918 832,769
2022-12-31 $30,314,010 1,668,355
2022-09-30 $24,891,856 1,668,355
2020-03-31 $521,637 126,611